Skip to main content

Table 2 Multivariate analysis of platelet reactivity in the overall population

From: Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

  Coefficient (SE) t 95 % CI Exponentiated coefficient* p-value
Male gender 0.04 (0.09) 0.24 −0.13 to 0.21 1.04 0.6
Current smoking −0.15 (0.12) 1.48 −0.39 to 0.09 0.86 0.2
-Insulin-treated diabetes mellitus (vs non-diabetic status) 0.26 (0.11) 6.03 0.053 to 0.47 1.30 0.01
-Non insulin-treated diabetes mellitus (vs non-diabetic status) 0.04 (0.07) 0.34 −0.10 to 0.18 1.04 0.6
Ticagrelor (vs prasugrel) −0.88 (0.06) 217.9 −0.99 to −0.76 0.42 <0.001
Age 0.001 (0.003) 0.08 −0.005 to 0.007 1.001 0.8
Body mass index 0.006 (0.007) 0.88 −0.007 to 0.019 1.006 0.4
Creatinine clearance < 60 ml/min 0.10 (0.09) 1.09 −0.09 to 0.29 1.1 0.3
Statin 0.24 (0.18) 1.79 −0.11 to 0.60 1.27 0.2
Proton pump inhibitor 0.11 (0.12) 0.75 −0.14 to 0.35 1.11 0.4
Hypertension 0.04 (0.06) 0.41 −0.08 to 0.16 1.04 0.5
STEMI at admission −0.11 (0.06) 3.10 −0.23 to 0.01 0.90 0.08
  1. SE = standard error, CI = confidence interval, STEMI = ST-segment elevation myocardial infarction. *Exponentiated coefficient = e^Coefficient is the factor by which PR on the original scale is multiplied